BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 31612515)

  • 1. The effect of glucocorticoids on Thrombospondin-1, Osteocalcin and the Thrombospondin-1:Osteocalcin ratio in humans.
    Cesana-Nigro N; Keshvari S; Barclay JL; Sorbello J; Upham JW; Benham H; Anderson ST; Steiger N; Prins JB; Inder WJ
    Clin Endocrinol (Oxf); 2019 Dec; 91(6):728-736. PubMed ID: 31612515
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thrombospondin-1 is a glucocorticoid responsive protein in humans.
    Barclay JL; Petersons CJ; Keshvari S; Sorbello J; Mangelsdorf BL; Thompson CH; Prins JB; Burt MG; Whitehead JP; Inder WJ
    Eur J Endocrinol; 2016 Feb; 174(2):193-201. PubMed ID: 26578641
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The impact of different glucocorticoid replacement schedules on bone turnover and insulin sensitivity in patients with adrenal insufficiency.
    Suliman AM; Freaney R; Smith TP; McBrinn Y; Murray B; McKenna TJ
    Clin Endocrinol (Oxf); 2003 Sep; 59(3):380-7. PubMed ID: 12919163
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of single doses of dexamethasone and adrenocorticotrop hormone on serum bone markers in healthy subjects and in patients with adrenal incidentalomas and Cushing's syndrome.
    Majnik J; Szücs N; Patócs A; Tóth M; Balogh K; Varga I; Gláz E; Rácz K
    J Endocrinol Invest; 2004 Sep; 27(8):747-53. PubMed ID: 15636428
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The low-dose dexamethasone suppression test in patients with adrenal incidentalomas: comparisons with clinically euadrenal subjects and patients with Cushing's syndrome.
    Tsagarakis S; Kokkoris P; Roboti C; Malagari C; Kaskarelis J; Vlassopoulou V; Alevizaki C; Thalassinos N
    Clin Endocrinol (Oxf); 1998 May; 48(5):627-33. PubMed ID: 9666875
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnostic performance of salivary cortisol and serum osteocalcin measurements in patients with overt and subclinical Cushing's syndrome.
    Sereg M; Toke J; Patócs A; Varga I; Igaz P; Szücs N; Horányi J; Pusztai P; Czirják S; Gláz E; Rácz K; Tóth M
    Steroids; 2011 Jan; 76(1-2):38-42. PubMed ID: 20813120
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mortality Risk in Patients With Adrenal Insufficiency Using Prednisolone or Hydrocortisone: A Retrospective Cohort Study.
    Ngaosuwan K; Johnston DG; Godsland IF; Cox J; Majeed A; Quint JK; Oliver N; Robinson S
    J Clin Endocrinol Metab; 2021 Jul; 106(8):2242-2251. PubMed ID: 33993277
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quality of glucocorticoid replacement in adrenal insufficiency: clinical assessment vs. timed serum cortisol measurements.
    Arlt W; Rosenthal C; Hahner S; Allolio B
    Clin Endocrinol (Oxf); 2006 Apr; 64(4):384-9. PubMed ID: 16584509
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of glucocorticoids on corticosteroid binding globulin.
    Schlechte JA; Hamilton D
    Clin Endocrinol (Oxf); 1987 Aug; 27(2):197-203. PubMed ID: 3665128
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Daily adjustment of glucocorticoids by patients with adrenal insufficiency.
    Schöfl C; Mayr B; Maison N; Beuschlein F; Meyer G; Badenhoop K; Kienitz T; Quinkler M
    Clin Endocrinol (Oxf); 2019 Aug; 91(2):256-262. PubMed ID: 31050815
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Salivary cortisol in adrenal diseases].
    Løvås K; Husebye ES
    Tidsskr Nor Laegeforen; 2007 Mar; 127(6):730-2. PubMed ID: 17363984
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Usefulness of Time-Point Serum Cortisol and ACTH Measurements for the Adjustment of Glucocorticoid Replacement in Adrenal Insufficiency.
    Rousseau E; Joubert M; Trzepla G; Parienti JJ; Freret T; Vanthygem MC; Desailloud R; Lefebvre H; Coquerel A; Reznik Y;
    PLoS One; 2015; 10(8):e0135975. PubMed ID: 26317782
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bone metabolism and mass in women with Cushing's syndrome and adrenal incidentaloma.
    Francucci CM; Pantanetti P; Garrapa GG; Massi F; Arnaldi G; Mantero F
    Clin Endocrinol (Oxf); 2002 Nov; 57(5):587-93. PubMed ID: 12390331
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TSH ratio as a novel diagnostic method for Cushing's syndrome.
    Tamada D; Kitamura T; Takahara M; Tanaka T; Takeda M; Otsuki M; Shimomura I
    Endocr J; 2018 Aug; 65(8):841-848. PubMed ID: 29925743
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetic/pharmacodynamic modelling of effects of dexamethasone and prednisolone in combination with endogenous cortisol on lymphocyte counts and systemic markers of bone turn over and inflammation in healthy and asthmatic men.
    Dubois EF; Derks MG; Schweitzer DH; Zwinderman AH; Dekhuijzen PN; van Boxtel CJ
    Eur J Clin Pharmacol; 2004 Jul; 60(5):315-28. PubMed ID: 15150679
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Steroid withdrawal syndrome after successful treatment of Cushing's syndrome: a reminder.
    Bhattacharyya A; Kaushal K; Tymms DJ; Davis JR
    Eur J Endocrinol; 2005 Aug; 153(2):207-10. PubMed ID: 16061825
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A very high dose dexamethasone suppression test for differential diagnosis of Cushing's syndrome.
    al-Saadi N; Diederich S; Oelkers W
    Clin Endocrinol (Oxf); 1998 Jan; 48(1):45-51. PubMed ID: 9509067
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of once-daily, modified-release hydrocortisone versus standard glucocorticoid therapy on metabolism and innate immunity in patients with adrenal insufficiency (DREAM): a single-blind, randomised controlled trial.
    Isidori AM; Venneri MA; Graziadio C; Simeoli C; Fiore D; Hasenmajer V; Sbardella E; Gianfrilli D; Pozza C; Pasqualetti P; Morrone S; Santoni A; Naro F; Colao A; Pivonello R; Lenzi A
    Lancet Diabetes Endocrinol; 2018 Mar; 6(3):173-185. PubMed ID: 29229498
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Delayed adrenal insufficiency long after unilateral adrenalectomy: prolonged glucocorticoid therapy reduced reserved secretory capacity of cortisol.
    Kazama I; Komatsu Y; Ohiwa T; Sanayama K; Nagata M
    Int J Urol; 2005 Jun; 12(6):574-7. PubMed ID: 15985081
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reducing glucocorticoid dosage improves serum osteocalcin in patients with rheumatoid arthritis-results from the TOMORROW study.
    Tada M; Inui K; Sugioka Y; Mamoto K; Okano T; Koike T; Nakamura H
    Osteoporos Int; 2016 Feb; 27(2):729-35. PubMed ID: 26294294
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.